Search Results
You are looking at 1 - 3 of 3 items for
- Author: Weijie Zhao x
- Refine by access: All content x
Search for other papers by Chunfang Xu in
Google Scholar
PubMed
Department of Gynecology and Obstetrics, The First People’s Hospital of Guangzhou, Guangzhou, People’s Republic of China
Search for other papers by Weijie Zhao in
Google Scholar
PubMed
Search for other papers by Xixi Huang in
Google Scholar
PubMed
Search for other papers by Zhuxuan Jiang in
Google Scholar
PubMed
Shanghai Key Laboratory of Bioactive Small Molecules, Department of Pharmacy, Fudan University, Shanghai, People’s Republic of China
Search for other papers by Lu Liu in
Google Scholar
PubMed
Shanghai Key Laboratory of Bioactive Small Molecules, Department of Pharmacy, Fudan University, Shanghai, People’s Republic of China
Search for other papers by Liyuan Cui in
Google Scholar
PubMed
Search for other papers by Xinyi Li in
Google Scholar
PubMed
Search for other papers by Dajin Li in
Google Scholar
PubMed
Department of Gynecology and Obstetrics, The First People’s Hospital of Guangzhou, Guangzhou, People’s Republic of China
Search for other papers by Meirong Du in
Google Scholar
PubMed
Decidualization is the functional transformation process of endometrium in response to ovarian steroids dedicated to support embryo development. Defective decidualization is closely associated with various pregnancy complications such as recurrent miscarriage (RM). Dual specificity MAPK phosphatases (MKPs) are a family of phosphatases specifically regulating mitogen-activated protein kinase (MAPK) signaling with dual specificity for threonine and tyrosine. Here, using RNA-seq,we found that dual specificity phosphatase 1 (DUSP1) expression was prominently elevated among the MKP family members in db-cAMP treated primary human endometrial stromal cells (ESCs). We verified that its induction by db-cAMP in ESCs was in a dose- and time-dependent manner and that primary human decidual stromal cells (DSCs) present higher expression of DUSP1 than ESCs. A protein kinase A (PKA) inhibitor H-89 abolished its induction in ESCs, but not ESI-09, an EPAC1/2 inhibitor. Knock-down of TORC2/3 but not CREB by siRNA in ESCs diminished its induction by db-cAMP. Furthermore, knock-down of DUSP1, as well as TORC2/3 by siRNA caused abnormal activation of JNK during db-cAMP induction in ESCs, accompanied by decreased IGFBP1 expression, an ESC decidualization indicator, which could be fully rescued by a JNK inhibitor SP600125. In addition, Western blot showed that DUSP1 expression was reduced in the DSCs of patients with RM, along with JNK overactivation and decreased IGFBP1 expression. In conclusion, our results demonstrated that TORC2/3-mediated DUSP1 upregulation in response to the cAMP/PKA signaling safeguards IGFBP1 expression via restraining JNK activity, indicating its involvement in ESC decidualization, and that aberrant expression of DUSP1 in DSCs might engage in the pathogenesis of RM.
Search for other papers by Xinyi Li in
Google Scholar
PubMed
Search for other papers by Jiaxin Shi in
Google Scholar
PubMed
Search for other papers by Weijie Zhao in
Google Scholar
PubMed
Search for other papers by Xixi Huang in
Google Scholar
PubMed
Shanghai Key Laboratory of Bioactive Small Molecules, Department of Pharmacy, Fudan University, Shanghai, China
Search for other papers by Liyuan Cui in
Google Scholar
PubMed
Shanghai Key Laboratory of Bioactive Small Molecules, Department of Pharmacy, Fudan University, Shanghai, China
Search for other papers by Lu Liu in
Google Scholar
PubMed
Search for other papers by Xueling Jin in
Google Scholar
PubMed
Search for other papers by Djin Li in
Google Scholar
PubMed
Search for other papers by Xuan Zhang in
Google Scholar
PubMed
State Key Laboratory of Quality Research in Chinese Medicine and School of Pharmacy, Macau University of Science and Technology, Macau SAR, China
Search for other papers by Meirong Du in
Google Scholar
PubMed
Decidual stromal cells (DSCs) modulate the function of trophoblasts through various factors. Wnt signaling pathway is active at the maternal–fetal interface. Here, we isolated endometrial stromal cells (ESCs) from women of reproductive ages and DSCs from normal pregnancy during the first trimester (6–10 weeks). Real-time quantitative PCR and western blotting were used to screen out the most variable WNT ligands between ESCs and DSCs, which turned out to be WNT16. Both culture mediums from DSCs and recombinant protein of human WNT16 enhanced the survival and invasion of HTR8/SVneo trophoblastic cells. Furthermore, the regulation of DSCs on trophoblast was partly blockaded after we knocked down WNT16 in DSCs. Treating HTR8/SVneo trophoblastic cells with small molecular inhibitors and small interfering RNA (siRNA), we found that the activity of AKT/beta-catenin (CTNNB1) correlated with the effect of WNT16. The crosstalk of WNT16/AKT/beta-catenin between DSCs and trophoblasts was determined to be downregulated in unexplained recurrent spontaneous abortion. This study suggests that WNT16 from DSCs promotes HTR8/SVneo trophoblastic cells invasion and survival via AKT/beta-catenin pathway at the maternal–fetal interface in human early pregnancy. The disturbance of this crosstalk between DSCs and trophoblasts might cause pregnancy failure.
Search for other papers by Lin Chen in
Google Scholar
PubMed
Laboratory for Reproductive Immunology, NHC Key Lab of Reproduction Regulation (Shanghai Institute of Planned Parenthood Research), Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Hospital of Obstetrics and Gynecology, Fudan University Shanghai Medical College, Shanghai, China
Search for other papers by Weijie Zhao in
Google Scholar
PubMed
Search for other papers by Mengxiong Li in
Google Scholar
PubMed
Search for other papers by Yazhu Yang in
Google Scholar
PubMed
Search for other papers by Chengzi Tian in
Google Scholar
PubMed
Search for other papers by Dengyang Zhang in
Google Scholar
PubMed
Search for other papers by Zhiguang Chang in
Google Scholar
PubMed
Search for other papers by Yunzhe Zhang in
Google Scholar
PubMed
Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States
Search for other papers by Zhizhuang Joe Zhao in
Google Scholar
PubMed
Search for other papers by Yun Chen in
Google Scholar
PubMed
Search for other papers by Lin Ma in
Google Scholar
PubMed
In brief
The establishment and maintenance of embryo implantation and pregnancy require decidualization of endometrial stromal cells. This paper reveals that SHP2 ensures the correct subcellular localization of progesterone receptor, thereby safeguarding the process of decidualization.
Abstract
Decidualization is the process of conversion of endometrial stromal cells into decidual stromal cells, which is caused by progesterone production that begins during the luteal phase of the menstrual cycle and then increases throughout pregnancy dedicated to support embryonic development. Decidualization deficiency is closely associated with various pregnancy complications, such as recurrent miscarriage (RM). Here, we reported that Src-homology-2-containing phospho-tyrosine phosphatase (SHP2), a key regulator in the signal transduction process downstream of various receptors, plays an indispensable role in decidualization. SHP2 expression was upregulated during decidualization. SHP2 inhibitor RMC-4550 and shRNA-mediated SHP2 reduction resulted in a decreased level of phosphorylation of ERK and aberrant cytoplasmic localization of progesterone receptor (PR), coinciding with reduced expression of IGFBP1 and various other target genes of decidualization. Solely inhibiting ERK activity recapitulated these observations. Administration of RMC-4550 led to decidualization deficiency and embryo absorption in mice. Moreover, reduced expression of SHP2 was detected in the decidua of RM patients. Our results revealed that SHP2 is key to PR's nuclear localization, thereby indispensable for decidualization and that reduced expression of SHP2 might be engaged in the pathogenesis of RM.